Sentence examples for native cancer from inspiring English sources

Tumour cell spheroids have many characteristics in common with native cancer, such as gradients for oxygen/hypoxia, nutrients, lactate accumulation, and proliferation and as such they resemble small stroma-embedded cancer cell nests [ 23].

Consequently, murine cancer cells either modified by IL-12 encoding plasmids or retrovirally transduced ex vivo [ 32- 34] were able to immunize against the native cancer cell line and to protect against the tumor cells in consecutive challenge experiments.

Finally, TVECs in human native cancers such as cervical and breast cancers were found to be defective in phenotype and function (VWF expression).

The SIRs for lip and liver cancers were more elevated in women than men, whereas the excess risk for native renal cancer was found in men only (Table 1).

In this regard, a Native Hawaiian cancer network called the Imi Hale is attempting, along with support from the National Cancer Institute, to increase screening for colorectal cancer in Native Hawaiians.[ 27] One limitation of this study is that data are restricted to the state of Hawaii.

Although rates are lower than that of the native population, breast cancer remains the most common cancer among South Asian women (Harding and Rosato, 1999; Winter et al, 1999).

A limitation of the present study is the fact that native SA gastric cancer patients were significantly younger compared to Caucasian SA and UK gastric cancer patients.

IGF-axis protein expression was a predictor of mortality risk in Native Hawaiian breast cancer patients—a group who suffer disparately high incidence and mortality rates for this cancer.

12 A greater proportion of Native Hawaiian breast cancer patients have a history of obesity (40%) compared to Caucasian, Japanese, and Latino breast cancer patients (P < 0.001).

Two out of nine (22%) Caucasian SA gastric cancers, six out of 25 (24%) native SA gastric cancers, and one out of 333(3%) UK gastric cancers showed MSI.

However, clinical use of TRAIL is impeded by its short in vivo half-life and native TRIAL-resistant cancer cell populations.